Bolivian Market Now Open to U.S. Red Meat

Jun 22, 2020

According to the USDA Food Safety and Inspection Service’s new Export Library entry for Bolivia, U.S. meat and meat products produced in the U.S. are eligible, along with casings derived from livestock slaughtered under inspection in the United States.

All federally inspected plants are eligible for export, but USMEF is seeking information on the specific company and product registration details for Bolivia.

Last year Bolivia reported beef imports of 1,831 metric tons (mt), mainly from Brazil along with small volumes from Argentina. Imports were valued at $2.6 million. Pork imports, which were almost entirely from Brazil, totaled 443 mt valued at about $1 million.

Bolivia’s imports of sausages, which are mainly from Brazil, totaled more than 5,000 mt in 2016 (valued at $5.7 million, suggesting low-cost poultry sausages might account for most of the trade) but were reported at just 446 mt last year, valued at $474,000. Bolivia also imports prepared beef products from Brazil (1,422 mt in 2019, valued at $1.7 million) and small volumes of prepared pork products.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.